Cholera: Clinical Trials

12 trials for Cholera, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed. 12 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 312Completed 12
Phase 21Completed 1

Follow Cholera: new trials by email Literature Review of Cholera trials Research Report on Cholera

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea
Next Generation ORS (oral rehydration solution) (including placebo, Current standard control ORS (oral rehydration solution) - Diarrhea, Cholera
Phase 2 / Phase 3CompletedUniversity of Florida3962023-08-212026-04-14
Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™
Oral Cholera Vaccine Simplified (OCV-S), Shanchol™ - Cholera
Phase 3CompletedInternational Vaccine Institute25302021-10-062023-06-22
A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic
Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell - Cholera
Phase 3CompletedSanofi Pasteur, a Sanofi Company3362015-04-012018-03-26
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
PXVX0200, Placebo - Cholera
Phase 3CompletedBavarian Nordic3982014-05-012023-06-28
A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults
PXVX0200 Lot A, PXVX0200 Lot B, PXVX0200 Lot C - Cholera
Phase 3CompletedBavarian Nordic31462014-05-012023-06-28
Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera
PXVX0200, placebo - Cholera
Phase 3CompletedBavarian Nordic1972013-09-012023-06-28
Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh
Shanchol, Placebo - Cholera
Phase 3CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh2044382012-12-092018-03-20
Ciprofloxacin Multiple Dose for Adult Cholera
Ciprofloxacin, Azithromycin - Cholera
Phase 3CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh2182007-07-012011-07-12
Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata
bivalent killed whole cell oral cholera vaccine, Placebo - Diarrhea, Cholera
Phase 3CompletedInternational Vaccine Institute693292006-07-012014-07-31
Single Dose Azithromycin in the Treatment of Adult Cholera
Azithromycin - Cholera
Phase 3CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh2202002-12-012006-07-21
Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial
Ciprofloxacin - Cholera
Phase 3CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh1802001-05-012022-02-11
Zinc Supplementation in Cholera Patients
Zinc - Cholera
Phase 3CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh2000-11-012005-10-20

Narrower conditions

Diarrhea (2)  ·  Vibrio Infections (1)

Broader conditions

Bacterial Infections (12)  ·  Bacterial Infections and Mycoses (12)  ·  Gram-Negative Bacterial Infections (12)  ·  Infections (12)  ·  Vibrio Infections (11)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Signs and Symptoms, Digestive (2)

Interventions

shanchol (3)  ·  Azithromycin (2)  ·  Ciprofloxacin (2)  ·  Calcium (1)  ·  World Health Organization oral rehydration solution (1)  ·  Zinc (1)

Sponsors

International Centre for Diarrhoeal Disease Research, Bangladesh (5)  ·  Bavarian Nordic (3)  ·  International Vaccine Institute (2)  ·  Sanofi Pasteur, a Sanofi Company (1)  ·  University of Florida (1)

Countries

Bangladesh (6)  ·  United States (3)  ·  Australia (1)  ·  Dominican Republic (1)  ·  India (1)  ·  Nepal (1)

Top investigators

James McCarty, MD (3)  ·  Debasish Saha, MBBS,MS (2)  ·  Dipika Sur, MD (1)  ·  Julia Lynch, MD (1)  ·  Sam Cheng, MD. PhD (1)  ·  Swapan K Roy, MBBS,MSc,Phd (1)  ·  Wasif A Khan, MBBS, MS (1)

Results publications

PMID 16182896, PMID 16760445, PMID 18184631, PMID 19761838, PMID 19819004, PMID 21907255, PMID 22028938, PMID 23362293, PMID 24161413, PMID 27001804, PMID 27144848, PMID 27622507, PMID 28566334, PMID 29317118, PMID 29463233, PMID 29470934, PMID 29550406, PMID 29624592, PMID 29655627, PMID 30772070, PMID 31092224, PMID 31743334, PMID 31879124, PMID 38023545, PMID 38614631

NIH funding

R21AI169282 (1)